Home > Newsletters > International Pharmaceutical Regulatory Monitor > Mexico Taking Closer Look at Clinical Trial Protocols, Investigator Sites
International Pharmaceutical Regulatory Monitor
October 2012 | Vol. 40 No. 10
Mexico Taking Closer Look at Clinical Trial Protocols, Investigator Sites
Mexico’s drug regulator Cofepris has doubled its clinical trial protocol review timeline, with approvals coming in six months now instead of three, an expert says.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.